P210005/S010: IC-8 Apthera Intraocular Lens (IOL)
FDA’s recorded scope: approval for continuing to conduct the PAS2 study under the currently approved protocol, SAIL-101-PAS2 Protocol Version 3.2, as approved under P210005/S004
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 2 FDA records to the applicant name Acu Focus, Inc.. 2 entries are PMA supplements. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Aug 4, 2025 to Jul 14, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code POE appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P210005, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 32 Discovery Suite 200, Irvine, CA, 92618. Recorded on P210005/S010, decision dated Jul 14, 2026.
FDA’s recorded scope: approval for continuing to conduct the PAS2 study under the currently approved protocol, SAIL-101-PAS2 Protocol Version 3.2, as approved under P210005/S004
FDA’s recorded scope: approval for a change to the address block of your labeling for the IC-8 Apthera IOL to align with other IOLs in the Bausch & Lomb portfolio
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
IC-8 Apthera Intraocular Lens (IOL)P210005/S010 | Acu Focus, Inc. | PMA supplement | Jul 14, 2026 | FDA |
IC-8 Apthera Intraocular Lens (IOL)P210005/S011 | Acu Focus, Inc. | PMA supplement | Aug 4, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.